Major Established

描述

Azithromycin and ondansetron both prolong the cardiac QT interval; their combination substantially increases the risk of torsades de pointes.

机制

Both drugs are hERG channel blockers; additive reduction in IKr potassium current prolongs the QTc interval in a dose-dependent, additive fashion.

临床意义

FDA issued safety communications for both drugs individually; combined use has been associated with arrhythmia events in case reports.

处理措施

Avoid concurrent use; select alternative antiemetics or antibiotics; monitor ECG and correct hypokalemia and hypomagnesemia if combination is essential.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.